Financials
Financial year 2025
MDN Pharmaceutics from Brussel, company number BE1032175218, closed financial year 2025 with a result of € -1,127 after tax. For that financial year MDN Pharmaceutics recorded a gross margin of € -1,127 and equity of € 873. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 873
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,127
Profit after tax over the fiscal year.
€ 647
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1,127.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,127
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to MDN Pharmaceutics?
What happened at MDN Pharmaceutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,127. filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Anbar Meddoun became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at MDN Pharmaceutics? We notify you, reason included.
Follow MDN PharmaceuticsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MDN Pharmaceutics is Anbar Meddoun.
Directors
According to the 2025 annual accounts
Anbar Meddoun
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Ieperlaan 34 box 402
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1032.175.218
- VAT number
- BE 1032.175.218
- Registered office
- Ieperlaan 34 bus 402, 1000 Brussel
- Names & denominations
- MDN Pharmaceutics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2025
- Peppol
- Active · Active since 13 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Bemiddelingsactiviteiten in verband met geneeskundige, tandheelkundige en andere diensten in verband met de menselijke gezondheid
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Bemiddelingsactiviteiten voor de gespecialiseerde detailhandel
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen